Clinical Trial Update: A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epinastine nasal spray for Seasonal Allergic Rhinitis has completed. The study assessed safety and efficacy in affected subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Epinastine nasal spray (epinastine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED